Takeda’s dengue vaccine QDENGA gets DCGI approval for use in India
Takeda’s QDENGA, the first dengue vaccine approved in India, is now authorised for individuals aged 4-60. The DCGI granted market authorisation without the need for pre-vaccination testing, marking a significant step in India’s dengue prevention. Takeda Biopharmaceuticals India Pvt Ltd. today announced that the Drug Controller General of India (DCGI) has granted market authorisation (CT-20, … Read more